IV Infusion News
Featured & Company News
Learn more about specialty infusion services and how Infusion Ventures are leaders in providing expert nursing care throughout New England.
Specialty Infusion is home infusion of specialty medications used to target and treat complex medical conditions. These medications are often very expensive and require special handling which our well trained nurses apply in the comfort of your own home or physician’s...
Our commitment to training is why Infusion Ventures is the leader in providing expert intravenous drug administration nursing services to our patients throughout New England.
In the ever changing world of medicine and healthcare services, our skilled nursing staff is dedicated to ongoing training and demonstrates continuous compliance to our rigorous performance standards. Infusion Ventures has an unwavering focus on cleanliness and...
Working together with specialty pharmacies, physicians, and our patients, Infusion Ventures are experts in coordinating your at home intravenous drug administration services away from a hospital environment.
Our team at Infusion Ventures is ready and capable of managing your home infusion therapy needs. Infusion Ventures bridges the gap between physician, patient, specialty or home infusion pharmacy and our specially trained infusion nurses. Serving all of New England, we...
Jump start your nursing career with a new nursing job! Infusion Ventures has infusion nursing jobs available throughout New England. Call us at (781) 938-7070 to learn more.
We are actively seeking RNs to infuse patients in their own homes and invite you to reach out to us today. Infusion Ventures is currently hiring licensed RNs to infuse patients in the comfort of their own homes. Our infusion nursing team supports both on demand...
Industry News
‘Reverse Vaccination’ May Help Prevent Immune Response | Hemophilia News Today
From Hemophilia News Today: A newly designed platform based on the principle of “reverse vaccination” could be used to prevent the development of an immune response that blocks the effectiveness of treatments for hemophilia and other disorders. Continue reading:...
Advocates Lobby US Congress During Virtual Rare Disease Week
This year’s event featured 250 patient organizations and 367 meetings with Congress. Original Source: Advocates Lobby US Congress During Virtual Rare Disease Week
Statement from NHIA on CMS’ Medicare Payment Rate Increase for Monoclonal Antibody Treatments
Earlier this year, The NHIA (The National Home Infusion Association) issued a statement regarding the decision to increase Medicare payment rates for monoclonal antibody administration. See the original press release below for more details. Alexandria, Va. (May 6,...
COVID-19 Vaccines and Primary Immunodeficiency | CSL Behring
Can PI patients get the vaccine and will it work for them? A doctor who advises the Immune Deficiency Foundation offers her perspective. Source article: COVID-19 Vaccines and Primary Immunodeficiency
Should Parents Be Freaking Out About a New COVID Syndrome Found in Kids?
Doctors have had success using treatment methods that are already widely known to be effective for inflammatory symptoms in children, including intravenous immunoglobulin, or IVIG. Source: Should Parents Be Freaking Out About a New COVID Syndrome Found in Kids?
Examining the Application of Ig in Multiple Disease States | IgNS – Advancing Ig Therapy Practice
Examining the Application of Immunoglobulin in Multiple Disease States: A Review of Evidence Source: Examining the Application of Ig in Multiple Disease States | IgNS - Advancing Ig Therapy Practice
Update on Crohn’s Disease from IG Living
Update on Crohn's Disease from IG Living or [button...
Hemophilia A Patients Using Hemlibra Show Gains in Joint Health, Trial Data Show | Hemophilia News Today
Source: Hemophilia A Patients Using Hemlibra Show Gains in Joint Health, Trial Data Show
Breaking into the Boys Club: Women with Hemophilia
Since hemophilia was discovered, it has been accepted as a male disease. No one questions that a man is struggling with hemophilia. A man with a bleeding disorder living in a developed country is rarely denied access to healthcare. When he receives a diagnosis, he is...
Data: Hemlibra OK in Kids with Hemophilia A Regardless of Inhibitor Status
Preventive treatment with Hemlibra reduces bleeding rates in children younger than 12 with hemophilia type A regardless of inhibitor status, data show. Source: Data: Hemlibra OK in Kids with Hemophilia A Regardless of Inhibitor Status